Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jovan Perunicic

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Prostaglandins, Leukotrienes, and Essential Fatty Acids|May 10, 2006
Adenosine cardioprotection study in clinical setting of paroxysmal supraventricular tachycardiaIvana I Vranic, Mihailo Matic, Jovan Perunicic, et al.
Journal of Science and Medicine in Sport|May 11, 2010
Echocardiographic study of early left ventricular remodeling in highly trained preadolescent footballersMarija Zdravkovic, Jovan Perunicic, Mirjana Krotin, et al.
The Journal of Invasive Cardiology|July 7, 2010
Prognostic significance of the occurrence of acute heart failure after successful primary percutaneous coronary interventionLidija Savic, Igor Mrdovic, Jovan Perunicic, et al.
Journal of Interventional Cardiology|November 23, 2011
Impact of the combined left ventricular systolic and renal dysfunction on one-year outcomes after primary percutaneous coronary interventionLidija Savic, Igor Mrdovic, Jovan Perunicic, et al.
Journal of Interventional Cardiology|June 12, 2009
Development and validation of a risk scoring model to predict net adverse cardiovascular outcomes after primary percutaneous coronary intervention in patients pretreated with 600 mg clopidogrel: rationale and design of the RISK-PCI studyIgor Mrdovic, Lidija Savic, Jovan Perunicic, et al.
European Journal of Heart Failure|June 1, 2005
Prognostic significance of new atrial fibrillation and its relation to heart failure following acute myocardial infarctionMilika Asanin, Jovan Perunicic, Igor Mrdovic, et al.
European Heart Journal. Acute Cardiovascular Care|February 25, 2014
Efficacy and safety of tirofiban-supported primary percutaneous coronary intervention in patients pretreated with 600 mg clopidogrel: results of propensity analysis using the Clinical Center of Serbia STEMI RegisterIgor Mrdovic, Lidija Savic, Ratko Lasica, et al.
International Heart Journal|September 9, 2006
Temporal variations at the onset of spontaneous acute aortic dissectionRatko M Lasica, Jovan Perunicic, Igor Mrdovic, et al.
The Canadian Journal of Cardiology|March 7, 2013
Sex-related analysis of short- and long-term clinical outcomes and bleeding among patients treated with primary percutaneous coronary intervention: an evaluation of the RISK-PCI dataIgor Mrdovic, Lidija Savic, Milika Asanin, et al.
Heart and Vessels|September 15, 2012
Usefulness of the RISK-PCI score to predict stent thrombosis in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a substudy of the RISK-PCI trialIgor Mrdovic, Lidija Savic, Ratko Lasica, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Prostaglandins, Leukotrienes, and Essential Fatty Acids|May 10, 2006
Adenosine cardioprotection study in clinical setting of paroxysmal supraventricular tachycardiaIvana I Vranic, Mihailo Matic, Jovan Perunicic, et al.
Journal of Science and Medicine in Sport|May 11, 2010
Echocardiographic study of early left ventricular remodeling in highly trained preadolescent footballersMarija Zdravkovic, Jovan Perunicic, Mirjana Krotin, et al.
The Journal of Invasive Cardiology|July 7, 2010
Prognostic significance of the occurrence of acute heart failure after successful primary percutaneous coronary interventionLidija Savic, Igor Mrdovic, Jovan Perunicic, et al.
Journal of Interventional Cardiology|November 23, 2011
Impact of the combined left ventricular systolic and renal dysfunction on one-year outcomes after primary percutaneous coronary interventionLidija Savic, Igor Mrdovic, Jovan Perunicic, et al.
Journal of Interventional Cardiology|June 12, 2009
Development and validation of a risk scoring model to predict net adverse cardiovascular outcomes after primary percutaneous coronary intervention in patients pretreated with 600 mg clopidogrel: rationale and design of the RISK-PCI studyIgor Mrdovic, Lidija Savic, Jovan Perunicic, et al.
European Journal of Heart Failure|June 1, 2005
Prognostic significance of new atrial fibrillation and its relation to heart failure following acute myocardial infarctionMilika Asanin, Jovan Perunicic, Igor Mrdovic, et al.
European Heart Journal. Acute Cardiovascular Care|February 25, 2014
Efficacy and safety of tirofiban-supported primary percutaneous coronary intervention in patients pretreated with 600 mg clopidogrel: results of propensity analysis using the Clinical Center of Serbia STEMI RegisterIgor Mrdovic, Lidija Savic, Ratko Lasica, et al.
International Heart Journal|September 9, 2006
Temporal variations at the onset of spontaneous acute aortic dissectionRatko M Lasica, Jovan Perunicic, Igor Mrdovic, et al.
The Canadian Journal of Cardiology|March 7, 2013
Sex-related analysis of short- and long-term clinical outcomes and bleeding among patients treated with primary percutaneous coronary intervention: an evaluation of the RISK-PCI dataIgor Mrdovic, Lidija Savic, Milika Asanin, et al.
Heart and Vessels|September 15, 2012
Usefulness of the RISK-PCI score to predict stent thrombosis in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a substudy of the RISK-PCI trialIgor Mrdovic, Lidija Savic, Ratko Lasica, et al.
Pageof 2